Our latest news

We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.

Read our latest news to find out more about how we are helping to improve the understanding of liver disease.

Perspectum launches new multiorgan imaging offering, Atlas®, for pharma sponsors at The Liver Meeting Digital Experience™ (TLMdX) 2020 Posted: November 10, 2020

Perspectum Releases New Whitepaper on The Cost-Effectiveness of Including Imaging in Phase 3 NASH Trials Posted: October 20, 2020

Pharma LiverMultiScan

Join a Patient Registry Posted: October 13, 2020

New monitoring tool could be a positive change on the horizon for children with autoimmune hepatitis Posted: October 6, 2020

AIH LiverMultiScan New publication

Perspectum and UK Biobank help to uncover genetic marker associated with fatty liver disease Posted: September 24, 2020

LiverMultiScan Genetics Population Imaging New publication

New non-invasive MRI biomarker for liver disease could cut costs for drug trials Posted: September 22, 2020

LiverMultiScan Liver Disease NAFLD NASH New publication

How to Choose an Imaging Provider for Your Clinical Trial Posted: September 22, 2020

Pharma

Beyond the Biopsy Posted: September 8, 2020

First European guidance on the use of multiparametric MRI in fatty liver disease Posted: September 4, 2020

LiverMultiScan Liver Disease NAFLD NASH New publication